The Veterinary Bureau of the Ministry of Agriculture and Rural Affairs of the People’s Republic of China issued the Soliciting Public Opinions on the Good Manufacturing Practice for Veterinary Drugs (Revised Draft for Comment) on June 14, 2019, which is something big to the veterinary drug industry of China because it will significantly affect thousands of veterinary drug manufacturers. And this new edition of GMP for Veterinary Drugs will continue to produce influence in terms of management philosophies, technical requirements and standards, and regulatory pressure on the industry, which sufficient attention shall be given to.
It has been 17 years since the 2002 edition of GMP for Veterinary Drugs was issued, which clearly cannot adapt to the industry development needs, with the big development of the veterinary drug industry all those years. The issuing of a new GMP for Veterinary Drugs is an irresistible trend as seen from the latest situations of veterinary drug enterprises.
I’d like to analyze for the veterinary drug industry the new characteristics and new requirements of this new edition of GMP for Veterinary Drugs according to my rich experience in the industry and in conjunction with the European and U.S. GMP implementation experience as well as the development practice of the veterinary drug industry all those years.
